QuadraMed Announces Share Repurchase Program
17 Dezembro 2007 - 12:00PM
Business Wire
QuadraMed� Corporation (Amex:QD) today announced that its Board of
Directors has authorized a program to repurchase, with available
cash, up to $5 million of the Company�s common stock. The Company
anticipates that the repurchase program will begin immediately and
will continue for up to four months. The repurchase program is to
be conducted in accordance with Rule 10b5-1 and Rule 10b-18 under
the Securities Exchange Act of 1934. The Company intends to
repurchase its common stock from shareholders through registered
broker-dealers in open market purchase transactions and plans to
hold any shares repurchased as treasury shares. The Company plans
to use the repurchased shares for any purpose that its Board of
Directors determines to be advisable in accordance with applicable
law. The Company believes that the share repurchase program is
advisable at this time, and is in the best interests of the Company
and its shareholders, in light of the current trading price of the
Company�s common stock and the general market and economic
conditions affecting the Company. About QuadraMed Corporation
QuadraMed Corporation advances the success of healthcare
organizations through IT solutions that leverage quality care into
positive financial outcomes. QuadraMed provides real-world
solutions that help healthcare professionals deliver outstanding
patient care efficiently and cost-effectively. Behind the company�s
products and services is a staff of 750 professionals whose
experience and dedication have earned QuadraMed the trust and
loyalty of clients at over 2,000 healthcare provider facilities.
Cautionary Statement on Risks Associated with QuadraMed
Forward-Looking Statements This press release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995 by QuadraMed that are
subject to risks and uncertainties. The words "believe," "expect,"
"anticipate," "intend," "plan," "estimate," "may," "should,"
"could," and similar expressions are intended to identify such
statements. Forward-looking statements are not guarantees of future
performance and are to be interpreted only as of the date on which
they are made. QuadraMed undertakes no obligation to update or
revise any forward-looking statement except as required by law.
QuadraMed advises investors that it discusses risk factors and
uncertainties that could cause QuadraMed�s actual results to differ
from forward-looking statements in its periodic reports filed with
the Securities and Exchange Commission ("SEC"). QuadraMed�s SEC
filings can be accessed through the Investor Relations section of
our website, www.quadramed.com, or through the SEC�s EDGAR Database
at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833). QuadraMed
is a registered trademark of QuadraMed Corporation. All other
trademarks are the property of their respective holders.
Quadramed (AMEX:QD)
Gráfico Histórico do Ativo
De Set 2024 até Out 2024
Quadramed (AMEX:QD)
Gráfico Histórico do Ativo
De Out 2023 até Out 2024
Notícias em tempo-real sobre Quadramed Corp. da American Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de QuadraMed Corporation